Surgical Endoscopy

, Volume 31, Issue 3, pp 1142–1147 | Cite as

The effects of bariatric surgeries on nonalcoholic fatty liver disease

  • Tamadar Aldoheyan
  • Mazen Hassanain
  • Amnah Al-Mulhim
  • Atheer Al-Sabhan
  • Shaden Al-Amro
  • Fahad Bamehriz
  • Hisham Al-Khalidi
Article
First Online:
Received:
Accepted:

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is associated with obesity. Bariatric surgery has been shown to be the most effective method for weight reduction. However, no conclusive data exists on the effects of weight reduction surgery on NAFLD. This study aimed to characterize liver histology, metabolic status, and liver function changes in patients who underwent bariatric surgery, before and after the weight-reduction procedure. This is a phase 1 report of a prospective cohort study of patients who underwent bariatric surgery. Biopsies were obtained at baseline (intraoperatively) and 3 months postoperatively. Clinical characteristics, biochemical profile, and histopathological data [steatosis, NAFLD activity score (NAS), hepatocyte ballooning, lobular inflammation, and degree of fibrosis] were obtained at each time point. Twenty-seven patients were included (9 men and 18 women), and the median age was 35 ± 8 years old. At baseline, 3 patients had dyslipidemia, 4 had diabetes, and 5 patients had hypertension, which did not change at follow-up. The average body mass index decreased from 44.6 ± 7.8 to 34.2 ± 6.3 kg/m2 at follow-up (P < 0.001). On histopathology, 12 of the 18 patients with preoperative steatosis (median score 2) had reduced steatosis scores postoperatively (P = 0.025); fibrosis (median score 1) was also reduced in 17 patients (P = 0.012), and NAS was decreased from 4 (3–5) to 2 (1–3) (P = 0.004). The changes in lobular inflammation and hepatocyte ballooning were not statistically significant on follow-up. The phase 1 results of this study described the histopathological changes following weight reduction surgery and suggested that hepatic steatosis, fibrosis, and NAFLD activity score were reduced 3 months after surgery. This clinical trial is financially supported by the National Plan for Science, Technology and Innovation Program grant number (11-MED1910-02).

Keywords

Bariatric Gastric bypass Gastric banding Insulin resistance biliopancreatic diversion with duodenal switch Nonalcoholic fatty liver disease Obesity Steatosis Sleeve gastrectomy 

Notes

Acknowledgments

This clinical trial is financially supported by The National Plan for Science, Technology and Innovation Program Grant Number (11-MED1910-02).

Compliance with ethical standards

Disclosures

Authors T. Aldoheyan, M. Hassanian, A. Al-Mulhim, A. Al-Sabhan, S. Al-Amro, F. Bamehriz and H. Al Khalid have no conflicts of interest.

References

  1. 1.
    Dixon JB (2007) Surgical treatment for obesity and its impact on non-alcoholicsteatohepatitis. Clin Liver Dis 11:141–154CrossRefPubMedGoogle Scholar
  2. 2.
    Kamada Y, Takehara T, Hayashi N (2008) Adipocytokines and liver disease. J Gastroenterol 43:811–822CrossRefPubMedGoogle Scholar
  3. 3.
    Gholam PM, Kotler DP, Flancbaum LJ (2002) Liver pathology in morbidlyobese patients undergoing Roux-en-Y gastric bypass surgery. ObesSurg 12:49–51Google Scholar
  4. 4.
    Oliveira CP, Faintuch J, Rascovski A, Furuya CK Jr, Bastos Mdo S, Matsuda M et al (2005) Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD): Preliminary findings. ObesSurg 15:502–505Google Scholar
  5. 5.
    Frantzides CT, Carlson MA, Moore RE, Zografakis JG, Madan AK, Puumala S et al (2004) Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg 8:849–855CrossRefPubMedGoogle Scholar
  6. 6.
    Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR (2003) Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg 138:1240–1244CrossRefPubMedGoogle Scholar
  7. 7.
    Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100CrossRefPubMedGoogle Scholar
  8. 8.
    Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G et al (2006) Long-term follow-up of patients with NAFLD andelevated liver enzymes. Hepatology 44:865–873CrossRefPubMedGoogle Scholar
  9. 9.
    Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholicsteatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131CrossRefPubMedGoogle Scholar
  10. 10.
    Sanyal AJNASH (2011) A global health problem. Hepatol Res 41:670–674PubMedGoogle Scholar
  11. 11.
    Physical status: The use and interpretation of anthropometry. Reportof a WHO Expert Committee. World Health Organ Tech Rep Ser1995;854:1–452Google Scholar
  12. 12.
    State-specific prevalence of obesity among adults–United States, 2005.Morb Mortal Wkly Rep 2006;55:985–8Google Scholar
  13. 13.
    Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world: a growing challenge. N Engl J Med 356:213–215CrossRefPubMedGoogle Scholar
  14. 14.
    Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA, Arafah MR, Khalil MZ, Khan NB et al (2005) Obesity in Saudi Arabia. Saudi Med J 26:824–829PubMedGoogle Scholar
  15. 15.
    Angulo P, Lindor KD (2002) Non-alcoholic fatty liver disease. J GastroenterolHepatol 17(Suppl):S186–S190Google Scholar
  16. 16.
    Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E et al (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242:610–617PubMedPubMedCentralGoogle Scholar
  17. 17.
    Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80CrossRefPubMedGoogle Scholar
  18. 18.
    Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: mayo Clinic experiences with a hitherto unnamed disease. Mayo ClinProc 55:434–438Google Scholar
  19. 19.
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMedGoogle Scholar
  20. 20.
    Kirovski G, Schacherer D, Wobser H, Huber H, Niessen C, Beer C et al (2010) Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease ina hospital cohort and its association with anthropometric, biochemicaland sonographic characteristics. Int J Clin Exp Med 3:202–210PubMedPubMedCentralGoogle Scholar
  21. 21.
    Paschos P, Paletas K (2009) Non alcoholic fatty liver disease and metabolicsyndrome. Hippokratia 13:9–19PubMedPubMedCentralGoogle Scholar
  22. 22.
    Al-hamoudi W, El-Sabbah M, Ali S, Altuwaijri M, Bedewi M, Adam M et al (2012) Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study. Ann Saudi Med 32:288–292PubMedGoogle Scholar
  23. 23.
    Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the UnitedStates. Gastroenterology 124:71–79CrossRefPubMedGoogle Scholar
  24. 24.
    Spaulding L, Trainer T, Janiec D (2003) Prevalence of non-alcoholicsteatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg 13:347–349CrossRefPubMedGoogle Scholar
  25. 25.
    Moretto M, Kupski C, Mottin CC, Repetto G, Garcia Toneto M, Rizzolli J et al (2003) Hepatic steatosis in patients undergoing bariatric surgery andits relationship to body mass index and co-morbidities. Obes Surg 13:622–624CrossRefPubMedGoogle Scholar
  26. 26.
    Silverman EM, Sapala JA, Appelman HD (1995) Regression of hepatic steatosisin morbidly obese persons after gastric bypass. Am J Clin Pathol 104:23–31CrossRefPubMedGoogle Scholar
  27. 27.
    Dixon JB, Bhathal PS, Hughes NR, O’Brien PE (2004) Nonalcoholic fatty liverdisease: improvement in liver histological analysis with weight loss. Hepatology 39:1647–1654CrossRefPubMedGoogle Scholar
  28. 28.
    Padwal RS (2005) Characteristics of patients undergoing bariatric surgery inCanada. Obes Res 13:2052–2054CrossRefPubMedGoogle Scholar
  29. 29.
    Trus TL, Pope GD, Finlayson SR (2005) National trends in utilization andoutcomes of bariatric surgery. Surg Endosc 19:616–620CrossRefPubMedGoogle Scholar
  30. 30.
    Dixon JB, Anderson M, Cameron-Smith D, O’Brien PE (2004) Sustained weightloss in obese subjects has benefits that are independent of attainedweight. Obes Res 12:1895–1902CrossRefPubMedGoogle Scholar
  31. 31.
    MacDonald KGJ, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL et al (1997) The gastric bypass operation reduces the progression andmortality of non-insulin-dependent diabetes mellitus. J GastrointestSurg 1:213–220CrossRefGoogle Scholar
  32. 32.
    Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S,et al. Acute effects of gastric bypass versus gastric restrictivesurgery on beta-cell function and insulinotropic hormones inseverely obese patients with type 2 diabetes. Int J Obes (Lond)2010;34:462–71Google Scholar
  33. 33.
    Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N et al (2006) Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130:1564–1572CrossRefPubMedGoogle Scholar
  34. 34.
    Moschen AR, Molnar C, Geiger S, Graziadei I, Ebenbichler CF, Weiss H et al (2010) Anti-inflammatory effects of excessive weight loss: potentsuppression of adipose interleukin 6 and tumour necrosis factor alphaexpression. Gut 59:1259–1264CrossRefPubMedGoogle Scholar
  35. 35.
    Clark JM, Alkhuraishi AR, Solga SF, Alli P, Diehl AM, Magnuson TH (2005) Roux-en-Y gastric bypass improves liver histology in patients withnon-alcoholic fatty liver disease. Obes Res 13:1180–1186CrossRefPubMedGoogle Scholar
  36. 36.
    Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M et al (2007) Effects of bariatric surgery on nonalcoholic fatty liverdisease: preliminary findings after 2 years. J Gastroenterol Hepatol 22:510–514CrossRefPubMedGoogle Scholar
  37. 37.
    Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R et al (2009) Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137:532–540CrossRefPubMedGoogle Scholar
  38. 38.
    Papadia F, Marinari GM, Camerini G, Adami GF, Murelli F, Carlini F et al (2003) Short-term liver function after biliopancreatic diversion. Obes Surg 13:752–755CrossRefPubMedGoogle Scholar
  39. 39.
    Keshishian A, Zahriya K, Willes EB (2005) Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after6 months. Obes Surg 15:1418–1423CrossRefPubMedGoogle Scholar
  40. 40.
    Burza MA, Romeo S, Kotronen A, Svensson PA, Sjöholm K, Torgerson JS, Lindroos AK, Sjöström L, Carlsson LM, Peltonen M (2013) Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS ONE 8(3):e60495CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Surgery, College of MedicineKing Saud UniversityRiyadhSaudi Arabia
  2. 2.Department of Pathology, College of MedicineKing Saud UniversityRiyadhSaudi Arabia
  3. 3.Liver Disease Research Centre, College of MedicineKing Saud UniversityRiyadhSaudi Arabia
  4. 4.Department of OncologyMcGill UniversityMontrealCanada
  5. 5.Hubert Department of Global HealthEmory UniversityAtlantaUSA

Personalised recommendations